Loading…
Mitochondrion as a Selective Target for the Treatment of Atherosclerosis: Role of Mitochondrial DNA Mutations and Defective Mitophagy in the Pathogenesis of Atherosclerosis and Chronic Inflammation
Background: Atherosclerosis is a chronic inflammatory condition that affects different arteries in the human body and often leads to severe neurological complications, such as stroke and its sequelae. Affected blood vessels develop atherosclerotic lesions in the form of focal thickening of the intim...
Saved in:
Published in: | Current neuropharmacology 2020-01, Vol.18 (11), p.1064-1075 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-b606t-6b1625921feb3046b1db8db3e6f458ea16bf7a662dff53c952da58a42ad1c593 |
---|---|
cites | cdi_FETCH-LOGICAL-b606t-6b1625921feb3046b1db8db3e6f458ea16bf7a662dff53c952da58a42ad1c593 |
container_end_page | 1075 |
container_issue | 11 |
container_start_page | 1064 |
container_title | Current neuropharmacology |
container_volume | 18 |
creator | Orekhov, Alexander N Poznyak, Anastasia V Sobenin, Igor A Nikifirov, Nikita N Ivanova, Ekaterina A |
description | Background: Atherosclerosis is a chronic inflammatory condition that affects different arteries in the human body and often leads to severe neurological complications, such as stroke and its sequelae. Affected blood vessels develop atherosclerotic lesions in the form of focal thickening of the intimal layer, so called atherosclerotic plaques.
Objectives: Despite the high priority of atherosclerosis research for global health and the numerous preclinical and clinical studies conducted, currently, there is no effective pharmacological treatment that directly impacts atherosclerotic plaques. Many knowledge gaps exist in our understanding of the mechanisms of plaque formation. In this review, we discuss the role of mitochondria in different cell types involved in atherogenesis and provide information about mtDNA mutations associated with the disease.
Results: Mitochondria of blood and arterial wall cells appear to be one of the important factors in disease initiation and development. Significant experimental evidence connects oxidative stress associated with mitochondrial dysfunction and vascular disease. Moreover, mitochondrial DNA (mtDNA) deletions and mutations are being considered as potential disease markers. Further study of mtDNA damage and associated dysfunction may open new perspectives for atherosclerosis treatment.
Conclusion: Mitochondria can be considered as important disease-modifying factors in several chronic pathologies. Deletions and mutations of mtDNA may be used as potential disease markers. Mitochondria-targeting antioxidant therapies appear to be promising for the development of treatment of atherosclerosis and other diseases associated with oxidative stress and chronic inflammation. |
doi_str_mv | 10.2174/1570159X17666191118125018 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7709151</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2316424457</sourcerecordid><originalsourceid>FETCH-LOGICAL-b606t-6b1625921feb3046b1db8db3e6f458ea16bf7a662dff53c952da58a42ad1c593</originalsourceid><addsrcrecordid>eNp1ks2O0zAQxyMEYpeFV0DmxqUQJ7GTcECqunystAsIeuBmOc64MSR2sJ1W-wK8Ge_FpC3VIkEOztjzn9-MPZMkz2j6IqNl8ZKyMqWs_kpLzjmtKaUVzVhKq3vJOa1KtsDD9D7aqFvMwrPkUQjf0jRjVVY-TM5ypOBXnye_bkx0qnO29cZZIgOR5Av0oKLZAllLv4FItPMkdrj1IOMANhKnyRJPvAuqn1cTXpHProfZcYcoe3L5YUlupigj4hFuW3IJ-oiflWMnN7fE2H2CTzJ2bgMWEPiPHPvwVeedNYpcWd3LYdiDHycPtOwDPDn-L5L12zfr1fvF9cd3V6vl9aLhKY8L3lCesTqjGpo8LXDbNlXb5MB1wSqQlDe6lJxnrdYsVzXLWskqWWSypYrV-UXy-oAdp2aAVuFLeNmL0ZtB-lvhpBF_e6zpxMZtRVmmNWUUAc-PAO9-TBCiGExQ0PfSgpuCyHLKi6woWInS-iBVePXgQZ_S0FTMUyD-OwUY-_RunafIP21Hwc-DoMFCOzkEZcAqOAm7GEex2-0ETB6-y7AfCKHcINwIdvI92jZirBi7UWDDPAjpo8FGCROC3dcm5uLE1vXTAIJWs2NCg4owyg0aKS_y3w7r56k</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2316424457</pqid></control><display><type>article</type><title>Mitochondrion as a Selective Target for the Treatment of Atherosclerosis: Role of Mitochondrial DNA Mutations and Defective Mitophagy in the Pathogenesis of Atherosclerosis and Chronic Inflammation</title><source>PubMed Central</source><creator>Orekhov, Alexander N ; Poznyak, Anastasia V ; Sobenin, Igor A ; Nikifirov, Nikita N ; Ivanova, Ekaterina A</creator><creatorcontrib>Orekhov, Alexander N ; Poznyak, Anastasia V ; Sobenin, Igor A ; Nikifirov, Nikita N ; Ivanova, Ekaterina A</creatorcontrib><description>Background: Atherosclerosis is a chronic inflammatory condition that affects different arteries in the human body and often leads to severe neurological complications, such as stroke and its sequelae. Affected blood vessels develop atherosclerotic lesions in the form of focal thickening of the intimal layer, so called atherosclerotic plaques.
Objectives: Despite the high priority of atherosclerosis research for global health and the numerous preclinical and clinical studies conducted, currently, there is no effective pharmacological treatment that directly impacts atherosclerotic plaques. Many knowledge gaps exist in our understanding of the mechanisms of plaque formation. In this review, we discuss the role of mitochondria in different cell types involved in atherogenesis and provide information about mtDNA mutations associated with the disease.
Results: Mitochondria of blood and arterial wall cells appear to be one of the important factors in disease initiation and development. Significant experimental evidence connects oxidative stress associated with mitochondrial dysfunction and vascular disease. Moreover, mitochondrial DNA (mtDNA) deletions and mutations are being considered as potential disease markers. Further study of mtDNA damage and associated dysfunction may open new perspectives for atherosclerosis treatment.
Conclusion: Mitochondria can be considered as important disease-modifying factors in several chronic pathologies. Deletions and mutations of mtDNA may be used as potential disease markers. Mitochondria-targeting antioxidant therapies appear to be promising for the development of treatment of atherosclerosis and other diseases associated with oxidative stress and chronic inflammation.</description><identifier>ISSN: 1570-159X</identifier><identifier>EISSN: 1875-6190</identifier><identifier>DOI: 10.2174/1570159X17666191118125018</identifier><identifier>PMID: 31744449</identifier><language>eng</language><publisher>United Arab Emirates: Bentham Science Publishers Ltd</publisher><ispartof>Current neuropharmacology, 2020-01, Vol.18 (11), p.1064-1075</ispartof><rights>Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.</rights><rights>2020 Bentham Science Publishers 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b606t-6b1625921feb3046b1db8db3e6f458ea16bf7a662dff53c952da58a42ad1c593</citedby><cites>FETCH-LOGICAL-b606t-6b1625921feb3046b1db8db3e6f458ea16bf7a662dff53c952da58a42ad1c593</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709151/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709151/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31744449$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Orekhov, Alexander N</creatorcontrib><creatorcontrib>Poznyak, Anastasia V</creatorcontrib><creatorcontrib>Sobenin, Igor A</creatorcontrib><creatorcontrib>Nikifirov, Nikita N</creatorcontrib><creatorcontrib>Ivanova, Ekaterina A</creatorcontrib><title>Mitochondrion as a Selective Target for the Treatment of Atherosclerosis: Role of Mitochondrial DNA Mutations and Defective Mitophagy in the Pathogenesis of Atherosclerosis and Chronic Inflammation</title><title>Current neuropharmacology</title><addtitle>CN</addtitle><description>Background: Atherosclerosis is a chronic inflammatory condition that affects different arteries in the human body and often leads to severe neurological complications, such as stroke and its sequelae. Affected blood vessels develop atherosclerotic lesions in the form of focal thickening of the intimal layer, so called atherosclerotic plaques.
Objectives: Despite the high priority of atherosclerosis research for global health and the numerous preclinical and clinical studies conducted, currently, there is no effective pharmacological treatment that directly impacts atherosclerotic plaques. Many knowledge gaps exist in our understanding of the mechanisms of plaque formation. In this review, we discuss the role of mitochondria in different cell types involved in atherogenesis and provide information about mtDNA mutations associated with the disease.
Results: Mitochondria of blood and arterial wall cells appear to be one of the important factors in disease initiation and development. Significant experimental evidence connects oxidative stress associated with mitochondrial dysfunction and vascular disease. Moreover, mitochondrial DNA (mtDNA) deletions and mutations are being considered as potential disease markers. Further study of mtDNA damage and associated dysfunction may open new perspectives for atherosclerosis treatment.
Conclusion: Mitochondria can be considered as important disease-modifying factors in several chronic pathologies. Deletions and mutations of mtDNA may be used as potential disease markers. Mitochondria-targeting antioxidant therapies appear to be promising for the development of treatment of atherosclerosis and other diseases associated with oxidative stress and chronic inflammation.</description><issn>1570-159X</issn><issn>1875-6190</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp1ks2O0zAQxyMEYpeFV0DmxqUQJ7GTcECqunystAsIeuBmOc64MSR2sJ1W-wK8Ge_FpC3VIkEOztjzn9-MPZMkz2j6IqNl8ZKyMqWs_kpLzjmtKaUVzVhKq3vJOa1KtsDD9D7aqFvMwrPkUQjf0jRjVVY-TM5ypOBXnye_bkx0qnO29cZZIgOR5Av0oKLZAllLv4FItPMkdrj1IOMANhKnyRJPvAuqn1cTXpHProfZcYcoe3L5YUlupigj4hFuW3IJ-oiflWMnN7fE2H2CTzJ2bgMWEPiPHPvwVeedNYpcWd3LYdiDHycPtOwDPDn-L5L12zfr1fvF9cd3V6vl9aLhKY8L3lCesTqjGpo8LXDbNlXb5MB1wSqQlDe6lJxnrdYsVzXLWskqWWSypYrV-UXy-oAdp2aAVuFLeNmL0ZtB-lvhpBF_e6zpxMZtRVmmNWUUAc-PAO9-TBCiGExQ0PfSgpuCyHLKi6woWInS-iBVePXgQZ_S0FTMUyD-OwUY-_RunafIP21Hwc-DoMFCOzkEZcAqOAm7GEex2-0ETB6-y7AfCKHcINwIdvI92jZirBi7UWDDPAjpo8FGCROC3dcm5uLE1vXTAIJWs2NCg4owyg0aKS_y3w7r56k</recordid><startdate>20200101</startdate><enddate>20200101</enddate><creator>Orekhov, Alexander N</creator><creator>Poznyak, Anastasia V</creator><creator>Sobenin, Igor A</creator><creator>Nikifirov, Nikita N</creator><creator>Ivanova, Ekaterina A</creator><general>Bentham Science Publishers Ltd</general><general>Bentham Science Publishers</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20200101</creationdate><title>Mitochondrion as a Selective Target for the Treatment of Atherosclerosis: Role of Mitochondrial DNA Mutations and Defective Mitophagy in the Pathogenesis of Atherosclerosis and Chronic Inflammation</title><author>Orekhov, Alexander N ; Poznyak, Anastasia V ; Sobenin, Igor A ; Nikifirov, Nikita N ; Ivanova, Ekaterina A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b606t-6b1625921feb3046b1db8db3e6f458ea16bf7a662dff53c952da58a42ad1c593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Orekhov, Alexander N</creatorcontrib><creatorcontrib>Poznyak, Anastasia V</creatorcontrib><creatorcontrib>Sobenin, Igor A</creatorcontrib><creatorcontrib>Nikifirov, Nikita N</creatorcontrib><creatorcontrib>Ivanova, Ekaterina A</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Current neuropharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Orekhov, Alexander N</au><au>Poznyak, Anastasia V</au><au>Sobenin, Igor A</au><au>Nikifirov, Nikita N</au><au>Ivanova, Ekaterina A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mitochondrion as a Selective Target for the Treatment of Atherosclerosis: Role of Mitochondrial DNA Mutations and Defective Mitophagy in the Pathogenesis of Atherosclerosis and Chronic Inflammation</atitle><jtitle>Current neuropharmacology</jtitle><addtitle>CN</addtitle><date>2020-01-01</date><risdate>2020</risdate><volume>18</volume><issue>11</issue><spage>1064</spage><epage>1075</epage><pages>1064-1075</pages><issn>1570-159X</issn><eissn>1875-6190</eissn><abstract>Background: Atherosclerosis is a chronic inflammatory condition that affects different arteries in the human body and often leads to severe neurological complications, such as stroke and its sequelae. Affected blood vessels develop atherosclerotic lesions in the form of focal thickening of the intimal layer, so called atherosclerotic plaques.
Objectives: Despite the high priority of atherosclerosis research for global health and the numerous preclinical and clinical studies conducted, currently, there is no effective pharmacological treatment that directly impacts atherosclerotic plaques. Many knowledge gaps exist in our understanding of the mechanisms of plaque formation. In this review, we discuss the role of mitochondria in different cell types involved in atherogenesis and provide information about mtDNA mutations associated with the disease.
Results: Mitochondria of blood and arterial wall cells appear to be one of the important factors in disease initiation and development. Significant experimental evidence connects oxidative stress associated with mitochondrial dysfunction and vascular disease. Moreover, mitochondrial DNA (mtDNA) deletions and mutations are being considered as potential disease markers. Further study of mtDNA damage and associated dysfunction may open new perspectives for atherosclerosis treatment.
Conclusion: Mitochondria can be considered as important disease-modifying factors in several chronic pathologies. Deletions and mutations of mtDNA may be used as potential disease markers. Mitochondria-targeting antioxidant therapies appear to be promising for the development of treatment of atherosclerosis and other diseases associated with oxidative stress and chronic inflammation.</abstract><cop>United Arab Emirates</cop><pub>Bentham Science Publishers Ltd</pub><pmid>31744449</pmid><doi>10.2174/1570159X17666191118125018</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1570-159X |
ispartof | Current neuropharmacology, 2020-01, Vol.18 (11), p.1064-1075 |
issn | 1570-159X 1875-6190 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7709151 |
source | PubMed Central |
title | Mitochondrion as a Selective Target for the Treatment of Atherosclerosis: Role of Mitochondrial DNA Mutations and Defective Mitophagy in the Pathogenesis of Atherosclerosis and Chronic Inflammation |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T14%3A03%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mitochondrion%20as%20a%20Selective%20Target%20for%20the%20Treatment%20of%20Atherosclerosis:%20Role%20of%20Mitochondrial%20DNA%20Mutations%20and%20Defective%20Mitophagy%20in%20the%20Pathogenesis%20of%20Atherosclerosis%20and%20Chronic%20Inflammation&rft.jtitle=Current%20neuropharmacology&rft.au=Orekhov,%20Alexander%20N&rft.date=2020-01-01&rft.volume=18&rft.issue=11&rft.spage=1064&rft.epage=1075&rft.pages=1064-1075&rft.issn=1570-159X&rft.eissn=1875-6190&rft_id=info:doi/10.2174/1570159X17666191118125018&rft_dat=%3Cproquest_pubme%3E2316424457%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b606t-6b1625921feb3046b1db8db3e6f458ea16bf7a662dff53c952da58a42ad1c593%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2316424457&rft_id=info:pmid/31744449&rfr_iscdi=true |